Olema Pharmaceuticals

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$1,884
Gross Profit
-94
-88
1,796
EBITDA
-33,436
-34,251
-30,328
EBIT
-33,530
-34,339
-30,416
Net Income
-30,382
-30,970
-26,772
Net Change In Cash
0
0
1,884
Free Cash Flow
-27,561
-23,649
-18,476
Cash
16,892
33,720
68,539
Basic Shares
56,282
55,574
54,783

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-377
-1,658
-1,663
-11
EBITDA
-104,584
-106,631
-69,433
-21,517
EBIT
-104,961
-106,988
-71,096
-21,528
Net Income
-96,655
-102,586
-70,886
-22,763
Net Change In Cash
0
0
0
0
Cost of Revenue
9,890
-324,737
Free Cash Flow
-83,727
-82,428
-52,265
-19,922
Cash
68,539
23,702
287,250
338,549
Basic Shares
45,247
39,995
39,524
39,308

Earnings Calls

Quarter EPS
2024-09-30
-$0.60
2024-06-30
-$0.54
2024-03-31
-$0.56
2023-12-31
-$0.49